Yiteng Jin

Ph.D. Candidate in Quantitative Biology at the Center for Quantitative Biology (CQB), Peking University (2021-2026). Research focuses on cancer immunology and tumor immunotherapy.

Selected Publication: The aryl hydrocarbon receptor (AHR) drives human leukocyte antigen (HLA)-II expression in human melanoma. Journal of Experimental & Clinical Cancer Research.

Current Position: Postdoctoral Fellow at the University of Pennsylvania (UPenn).